Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder

Charles L. Bowden; Eduard Vieta; Kathleen Ice; Jeffrey H. Schwartz; Paul P. Wang; Mark Versavel

doi:10.4088/jcp.09m05482yel

Related publications

Article2009

A 6-month, Randomized, Placebo-controlled, Double Blind Trial of Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder

Eduard Vieta, Charles L. Bowden, Kathleen Ice, Oksana Gurtovaya, Jeffrey H. Schwartz, P. Wang

Article2009

P.3.a.030 A 6-month, double-blind trial of ziprasidone plus a mood stabilizer in subjects with bipolar I disorder

Eduard Vieta, Charles L. Bowden, Kathleen Ice, Jeffrey H. Schwartz, P. Wang, M. Versavel, Onur N. Karayal

Article2011

Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles

David E. Kemp, Onur N. Karayal, Joseph R. Calabrese, Gary S. Sachs, Elizabeth Pappadopulos, Kathleen Ice, Cynthia Siu, Eduard Vieta

Article2022

T126. ADVANCING PHARMACOGENOMICS OF ANTICONVULSANT MOOD STABILIZER RESPONSE IN BIPOLAR DISORDER THROUGH THE MOOD STABILIZER GENOMICS (MOSTGEN) CONSORTIUM

Joanna M. Biernacka, Ada Man‐Choi Ho, Brandon J. Coombes, Susan L. McElroy, Alfredo Cuellar Barboza, Miguel A. Prieto, Eduard Vieta, Melvin G. McInnis, Bernhard T. Baune, Thomas G. Schulze, Boris Chaumette, Mirko Manchia, Alessandro Serretti, Martin Alda, Mark A. Frye

Article2020

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Thomas Yau, Yoon‐Koo Kang, Tae‐You Kim, Anthony B. El-Khoueiry, Armando Santoro, Bruno Sangro, Ignacio Melero, Masatoshi Kudo, Ming-Mo Hou, Ana Matilla, Francesco Tovoli, Jennifer J. Knox, Aiwu Ruth He, Bassel F. El‐Rayes, Mirelis Acosta-Rivera, Ho-Yeong Lim, Jaclyn Neely, Yun Shen, Tami Wisniewski, Jeffrey Anderson, Chiun Hsu